Skip to contentDeerfield Special Situations Fund, L.P. — Hana Biosciences Inc insider: 228 transactions · InsiderLensDeerfield Special Situations Fund, L.P.
- 10% owner at PAR PHARMACEUTICAL COMPANIES, INC. · on record since Feb 1, 2007
- 10% owner at INSPIRE PHARMACEUTICALS INC · on record since May 2, 2007
- 10% owner at CORAUTUS GENETICS INC · on record since Aug 24, 2007
- 10% owner at DYNAVAX TECHNOLOGIES CORP · on record since Jul 23, 2007
- 10% owner at DUSA PHARMACEUTICALS INC · on record since Nov 27, 2007
- 10% owner at EMAGEON INC · on record since Nov 27, 2007
- 10% owner at ANADYS PHARMACEUTICALS INC · on record since Oct 25, 2007
- 10% owner at NeurogesX Inc · on record since Mar 31, 2008
- 10% owner at XCYTE THERAPIES INC · on record since Mar 14, 2008
- 10% owner at NITROMED INC · on record since May 6, 2008
- 10% owner at NeuroMetrix, Inc. · on record since Dec 5, 2008
- 10% owner at NxStage Medical, Inc. · on record since Jun 19, 2009
- Possible Member of 10% Group at eHealth, Inc. · on record since Mar 9, 2015
- 10% owner at NOVELLUS SYSTEMS INC · on record since Jun 16, 2015
- 10% owner at LANVISION SYSTEMS INC · on record since Jul 13, 2015
- *Possible member of 10% group at FLAMEL TECHNOLOGIES SA · on record since Jun 25, 2018
- Possible Member of a 10% Group at Aclaris Therapeutics, Inc. · on record since Dec 27, 2018
Insider trading activity of Deerfield Special Situations Fund, L.P.
- Transactions on record
- 228
- since Mar 30, 2006
- Open-market buys
- 81
- $54.9M
- Open-market sells
- 112
- $17.3M
- Companies traded
- 20
- last filing Feb 12, 2019
Figures computed from official regulatory filings — methodology.
Companies where Deerfield Special Situations Fund, L.P. has traded
- Xeris Biopharma Holdings, Inc.2 tx · $109.3K · Feb 12, 2019
- Aclaris Therapeutics, Inc.1 tx · Jan 2, 2019
- BOLD ENERGY INC.10 tx · $6M · Jul 25, 2016
- eHealth, Inc.1 tx · $601K · Jun 16, 2016
- Vanda Pharmaceuticals Inc.18 tx · $13.7M · Dec 18, 2015
- ALIMERA SCIENCES INC12 tx · $2M · Dec 8, 2015
- LECTEC CORP /MN/1 tx · $1.9M · Sep 22, 2015
- Dicerna Pharmaceuticals Inc12 tx · $3.7M · Nov 25, 2014
- Avalanche Biotechnologies, Inc.27 tx · $31.9M · Aug 5, 2014
Track record of Deerfield Special Situations Fund, L.P.
Statistical track record
Free- Open-market buys
- 85
- Last buy
- Jul 25, 2016
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Deerfield Special Situations Fund, L.P.
Co-insiders of Deerfield Special Situations Fund, L.P.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
40 tx · $6.8M · May 7, 2012
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 12, 2019 | Sell | -5,890 | 15.11 USD | $89K | SEC |
| Feb 12, 2019 | Sell | -1,351 | 15.00 USD | $20.3K | SEC |
| Jan 2, 2019 | OtherD | 1 | — | — | SEC |
| Jul 25, 2016 | OtherD | -99,830 | — | — | SEC |
| Jul 25, 2016 | OtherD | -267,998 | — | — | SEC |
| Jul 25, 2016 | Other | 99,830 | — | — | SEC |
| Jul 25, 2016 | OtherD | -535,996 | — | — | SEC |
| Jul 25, 2016 | OtherD | -99,830 | — | — | SEC |
| Jul 25, 2016 | Buy | 253,404 | 15.00 USD | $3.8M | SEC |
| Jul 25, 2016 | Buy | 146,596 | 15.00 USD | $2.2M | SEC |
| Jul 25, 2016 | Other | 267,998 | — | — | SEC |
| Jul 25, 2016 | Other | 99,830 | — | — | SEC |
| Jul 25, 2016 | Other | 535,996 | — | — | SEC |
| Jun 16, 2016 | Sell | -43,300 | 13.88 USD | $601K | SEC |
| Dec 18, 2015 | Buy | 128,374 | 8.61 USD | $1.1M | SEC |
| Dec 18, 2015 | Buy | 100,864 | 8.61 USD | $868.4K | SEC |
| Dec 18, 2015 | Buy | 93,634 | 8.61 USD | $806.2K | SEC |
| Dec 18, 2015 | Buy | 40,997 | 8.59 USD | $352.2K | SEC |
| Dec 18, 2015 | Buy | 29,902 | 8.59 USD | $256.9K | SEC |
| Dec 18, 2015 | Buy | 32,211 | 8.59 USD | $276.7K | SEC |
| Dec 11, 2015 | Buy | 100,864 | 8.61 USD | $868.4K | SEC |
| Dec 11, 2015 | Buy | 11,506 | 9.00 USD | $103.6K | SEC |
| Dec 11, 2015 | Buy | 93,634 | 8.61 USD | $806.2K | SEC |
| Dec 11, 2015 | Buy | 229,833 | 8.21 USD | $1.9M | SEC |
| Dec 11, 2015 | Buy | 40,997 | 8.59 USD | $352.2K | SEC |